alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Clinical trials

Clinical trials

Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

Clear filters Download all 7,816 as CSV

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 1,976–2,000 of 7,816 matching trials · page 80 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial Phase Status Enrolled Sponsor Last updated
Care Coordination System for People With Dementia
NCT04308512
Active Nili device; Passive Nili system
Runs in: United States · 1 site 		NA
other		 COMPLETED 33 Bijan Najafi, PhD
OTHER		 2025-11-05
DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Clinical Relapse in Aggressive B-cell Non-Hodgkin Lymphomas
NCT02633111
collected at pre-treatment tumor biopsy; Peripheral blood tests; PET/CT
Runs in: United States · 12 sites 		NA
other		 ACTIVE_NOT_RECRUITING 501 Memorial Sloan Kettering Cancer Center
OTHER		 2025-11-04
Effect of an Advance Care Planning Intervention
NCT04852055
Advance Care Planning Video
Runs in: United States · 1 site 		NA
other		 COMPLETED 2,364 Brown University
OTHER		 2025-11-04
BRINK (BRain In Kidney Disease) Memory Study 2.0
NCT04975464
Runs in: United States · 2 sites 		NA
other		 ACTIVE_NOT_RECRUITING 600 Anne Murray
OTHER		 2025-11-04
A Technology-Driven Intervention to Improve Early Detection and Management of Cognitive Impairment
NCT05723523
CI-CDS
Runs in: United States · 2 sites 		NA
other		 COMPLETED 3,230 HealthPartners Institute
OTHER		 2025-11-04
Sex-specific Risk Factors and Trajectories of Blood Biomarkers for Alzheimer's Disease and Related Dementias
NCT07224139
Runs in: Australia; United States · 5 sites 		NA
other		 ACTIVE_NOT_RECRUITING 13,435 Anne Murray
OTHER		 2025-11-04
Aspirin in Reducing Events in the Elderly-Extension (ASPREE-XT)
NCT07224347
Runs in: Australia; United States · 36 sites 		NA
other		 ACTIVE_NOT_RECRUITING 19,114 Anne Murray
OTHER		 2025-11-04
U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk
NCT03688126
Self-Guided Lifestyle Intervention; Structured Lifestyle Intervention
Runs in: United States · 6 sites 		NA
other		 COMPLETED 2,000 Wake Forest University Health Sciences
OTHER		 2025-11-03
Testing the Feasibility of the Individualized Positive Psychosocial Intervention (IPPI)
NCT05980299
Individualized Positive Psychosocial Interaction
Runs in: United States · 7 sites 		NA
other		 COMPLETED 200 Miami University
OTHER		 2025-11-03
Study of Nasal Insulin to Fight Forgetfulness - Device Study
NCT03857321
Insulin; Placebo; intranasal nebulizer-like device
Runs in: United States · 1 site 		PHASE2
other		 COMPLETED 20 Wake Forest University Health Sciences
OTHER		 2025-10-31
Development of Novel Measures for Alzheimer's Disease Prevention Trials
NCT03900273
No Practice Effects (NPE) cognitive battery, and Miami Computerized...
Runs in: United States · 4 sites 		NA
other		 SUSPENDED 400 New York State Psychiatric Institute
OTHER		 2025-10-31
TabCAT Brain Health Assessment in Primary Care
NCT06090578
TabCAT Brain Health Assessment Clinical Pathway
Runs in: United States · 1 site 		NA
other		 RECRUITING 180,000 University of California, San Francisco
OTHER		 2025-10-31
Assess Fibrin in Brains With AD/ADRD
NCT05336695
PET/MR Imaging; 64Cu-FBP8
Runs in: United States · 1 site 		PHASE1|PHASE2
other		 RECRUITING 30 Massachusetts General Hospital
OTHER		 2025-10-30
Prescribing Trends and Associated Outcomes of Antiepileptic Drugs in US Nursing Homes Surrounding the COVID-19 Pandemic
NCT06095284
Pre-Extraction Phase; Extraction Phase; Post-Extraction Phase
Runs in: United States · 1 site 		NA
other		 ENROLLING_BY_INVITATION 22,500,000 Virginia Commonwealth University
OTHER		 2025-10-30
A Phase 1 Safety and Tolerability Study of TML-6 in Healthy and Elderly Volunteers for Alzheimer's Disease Treatment
NCT06562114
TML-6 Granules; Placebo
Runs in: United States · 1 site 		PHASE1
other		 COMPLETED 72 Merry Life Biomedical Co., Ltd.
INDUSTRY		 2025-10-30
Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation, and Irritability in Participants With Traumatic Brain Injury
NCT03095066
Placebo; AVP-786-28; AVP-786-42.63
Runs in: United States · 54 sites 		PHASE2
other		 COMPLETED 168 Otsuka Pharmaceutical Development & Commercialization, Inc.
INDUSTRY		 2025-10-29
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Dementia
NCT04522739
Spironolactone; Placebo
Runs in: United States · 1 site 		PHASE4
other		 COMPLETED 25 Emory University
OTHER		 2025-10-29
A Phase 2 Study to Evaluate Efficacy and Safety of AL002 in Participants With Early Alzheimer's Disease
NCT04592874
AL002; Placebo
Runs in: Argentina; Australia; Canada; France; Germany; Italy; Net... · 87 sites 		PHASE2
other		 COMPLETED 356 Alector Inc.
INDUSTRY		 2025-10-29
Clinical Trial Protocol: Alzheimer's Dementia Underlying Encephalopathy
NCT07222280
Quest AD-Detect blood test
Runs in: United States · 6 sites 		NA
other		 RECRUITING 30 Covenant Health, US
OTHER		 2025-10-29
Effect of Accelerated Neuromodulation of Anterior Cingulate Cortex to Enhance Cognition in Older Adults With Mild Memory Problems
NCT07212504
Active Brainsway H7-Coil Deep TMS System; Sham Brainsway H1-Coil De...
Runs in: Canada · 1 site 		NA
other		 RECRUITING 30 Rotman Research Institute at Baycrest
OTHER		 2025-10-28
Deep TMS for Comorbid Depression and Cognitive Impairment in Older Adults
NCT03665831
Brainsway H1-Coil Deep TMS System
Runs in: Canada · 1 site 		NA
other		 RECRUITING 28 Rotman Research Institute at Baycrest
OTHER		 2025-10-27
dTMS for Subjective Cognitive Decline
NCT06095063
Active Brainsway H7-Coil Deep TMS System; Sham Brainsway H7-Coil De...
Runs in: Canada · 1 site 		NA
other		 RECRUITING 30 Rotman Research Institute at Baycrest
OTHER		 2025-10-27
A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimer's Disease (ALTITUDE-AD)
NCT06335173
sabirnetug; Placebo
Runs in: Canada; Germany; Spain; United Kingdom; United States · 68 sites 		PHASE2
other		 ACTIVE_NOT_RECRUITING 542 Acumen Pharmaceuticals
INDUSTRY		 2025-10-27
STELLA-FTD: Examination of a Behavior Change Intervention for FTD Family Care Partners
NCT06613204
STELLA-FTD Control; STELLA-FTD Test
Runs in: United States · 1 site 		NA
other		 RECRUITING 640 Oregon Health and Science University
OTHER		 2025-10-27
A Study of Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD)
NCT02951598
Florbetapir F 18 PET Scan
Runs in: United States · 77 sites 		NA
other		 ACTIVE_NOT_RECRUITING 1,400 Eli Lilly and Company
INDUSTRY		 2025-10-24

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry
ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file
7,816
Source file
trials.csv (3.8 MB, 7816 rows)
Basis
Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

Related evidence Treatments → What the drugs that finished their trials actually achieved.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

All 162 studies on Clinical trials →